Curaleaf Holdings (CURLF) Operating Income Growth (3y) (2022 - 2026)
Curaleaf Holdings (CURLF) Operating Income Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.24 Bn | 87.37 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.21 Bn | 1.97 Bn | 273.62% |
| 3 | Zoetis | 32.51 Bn | 30.56 Bn | 1.62 Bn | 3.84% |
| 4 | Takeda Pharmaceutical | 27.58 Bn | 23.52 Bn | 4.39 Bn | -59.82% |
| 5 | United Therapeutics | 23.18 Bn | 21.02 Bn | 648.10 Mn | 4.63% |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - | - |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn | -30.05% |
| 8 | Neurocrine Biosciences | 17.94 Bn | 16.63 Bn | 800.70 Mn | 54.58% |
| 9 | Elanco Animal Health | 12.73 Bn | 12.30 Bn | 785.00 Mn | 40.17% |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn | -65.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -65.27% |
| Dec 31, 2025 | 28.59% |
| Sep 30, 2025 | -50.14% |
| Jun 30, 2025 | -54.60% |
| Mar 31, 2025 | -40.17% |
| Dec 31, 2024 | -34.84% |
| Sep 30, 2024 | -39.46% |
| Jun 30, 2024 | -47.90% |
| Mar 31, 2024 | -92.94% |
| Dec 31, 2023 | -91.53% |
| Sep 30, 2023 | -2.42% |
| Jun 30, 2023 | -30.00% |
| Mar 31, 2023 | 53.27% |
| Dec 31, 2022 | -123.86% |
| Sep 30, 2022 | 182.45% |